Aaron Smith, executive director of the National Cannabis Industry Association, called the increase in supply for marijuana research a small but positive step, but the DEA’s refusal to reschedule the drug “flies in the face of objective science and overwhelming opinion.”
Read more: http://www.spokesman.com/blogs/spincontrol/2016/aug/11/dea-wa-pot-has-no-medical-uses/
Follow NCIA
Newsletter
Facebook
Twitter
LinkedIn
Instagram
–